Social media announcement of PAC-832, a claimed novel Alzheimer's drug candidate
By
Douglas Yao
Summary
A post on X (formerly Twitter) announcing the invention of a new drug called PAC-832, described as the world's first selective GalR1 antagonist designed to treat Alzheimer's disease. The author claims to have designed and synthesized the drug in a home garage chemistry lab. The content is a brief social media post (part 1 of 16) with minimal detail.
Source
Hacker NewsSocial media announcement of PAC-832, a claimed novel Alzheimer's drug candidatetwitter.comKey quotes
· 3 pulledThis vial contains a new drug called PAC-832, which I recently invented to treat Alzheimer's disease.
It is the world's first selective GalR1 antagonist.
I designed and synthesized PAC-832 in a chemistry lab I built in my garage.
You might also wanna read
A better Alzheimer’s drug?
Deep-learning platform GPS enables de novo drug discovery by predicting transcriptomic perturbations from chemical structures
This paper presents GPS (gene expression profile predictor on chemical structures), a deep-learning-based drug discovery platform that scree
Baylor Researchers Discover Molecular Switch That Activates Astrocytes to Clear Alzheimer's Plaques
Researchers at Baylor College of Medicine discovered that activating a protein called Sox9 in astrocytes (a type of brain cell) triggers the
CMU Startup Pierogi Therapeutics Uses AI to Accelerate Radiopharmaceutical Cancer Drug Discovery
A Carnegie Mellon University startup called Pierogi Therapeutics is using AI and advanced chemistry to accelerate the discovery of cancer dr
cmu.edu·23d ago
Global protein-ligand binding affinity profiling via photocatalytic labeling
Comments
Sign in to join the conversation.
No comments yet. Be the first.